Loading fund…
Loading fund…
| Returns | 1D | 1M | 3M | YTD | 1Y | 3Y | 5Y | MAX |
|---|---|---|---|---|---|---|---|---|
| Total return | ▲ +1.1% | ▼ −3.3% | ▲ +13.0% | ▲ +61.2% | ▲ +100.5% | ▲ +358.2% | ▼ −75.1% | ▼ −91.6% |
| Peer average | ▲ +0.4% | ▲ +0.2% | ▼ −4.6% | ▲ +19.4% | ▲ +21.0% | ▲ +170.6% | ▲ +15.0% | — |
| S&P 500 · VOO | ▼ −0.4% | ▲ +0.9% | ▲ +3.3% | ▲ +13.8% | ▲ +13.3% | ▲ +88.8% | ▲ +81.9% | — |
Reported holdings are shown below. A share-of-fund chart is unavailable for this portfolio.
Holdings as of 2026-10-30. Derivatives are shown using their reported instrument names.
| Holding | Instrument | Weight |
|---|---|---|
| SPSIBI SWAP ASSET LEG (SPSIBICTL) | swap | 18.81% |
| SPSIBI SWAP ASSET LEG (SPSIBIUBL) | swap | 14.21% |
| SPSIBI SWAP ASSET LEG (SPSIBIMLL) | swap | 12.94% |
| SPSIBI SWAP ASSET LEG (SPSIBIBCL) | swap | 10.27% |
| SPSIBI SWAP ASSET LEG (SPSIBIJPL) | swap | 8.71% |
| GOLDMAN FINL SQ TRSRY INST 506 | Reported holding | 5.47% |
| SPSIBI SWAP ASSET LEG (SPSIBIBPL) | swap | 4.42% |
| DREYFUS GOVT CASH MAN INS | Reported holding | 4.15% |
| SPSIBI SWAP ASSET LEG (SPSIBIGSL) | swap | 0.77% |
| MRNAMODERNA INC | Reported holding | 0.48% |
| TWSTTWIST BIOSCIENCE CORP | Reported holding | 0.40% |
| NTRANATERA INC | Reported holding | 0.38% |
| HALOHALOZYME THERAPEUTICS INC | Reported holding | 0.35% |
| BIIBBIOGEN INC | Reported holding | 0.34% |
| AMGNAMGEN INC | Reported holding | 0.34% |
| UTHRUNITED THERAPEUTICS CORP | Reported holding | 0.34% |
| ABBVABBVIE INC | Reported holding | 0.34% |
| SYRESPYRE THERAPEUTICS INC | Reported holding | 0.33% |
| GILDGILEAD SCIENCES INC | Reported holding | 0.33% |
| EXELEXELIXIS INC | Reported holding | 0.33% |
| TGTXTG THERAPEUTICS INC | Reported holding | 0.31% |
| GRALGRAIL INC | Reported holding | 0.31% |
| ORKAORUKA THERAPEUTICS INC | Reported holding | 0.31% |
| VRTXVERTEX PHARMACEUTICALS INC | Reported holding | 0.30% |
| REGNREGENERON PHARMACEUTICALS | Reported holding | 0.29% |
| ALKSALKERMES PLC | Reported holding | 0.29% |
| CRSPCRISPR THERAPEUTICS AG | Reported holding | 0.29% |
| PTGXPROTAGONIST THERAPEUTICS INC | Reported holding | 0.29% |
| PTCTPTC THERAPEUTICS INC | Reported holding | 0.28% |
| NBIXNEUROCRINE BIOSCIENCES INC | Reported holding | 0.27% |
Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bull 3X ETF is an exchange traded fund launched by Direxion Investments. It is managed by Rafferty Asset Management, LLC. It invests in public equity markets of the United States. It invests directly, through derivatives and through other funds in stocks of companies operating across health care, pharmaceuticals, biotechnology and life sciences sectors. It uses derivatives such as futures, swaps to create its portfolio. The fund invests in growth and value stocks of companies across diversified market capitalization. It seeks to track 3x the daily performance of the S&P Biotechnology Select Industry Index. Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bull 3X ETF was formed on May 28, 2015 and is domiciled in the United States.
Distribution yield and SEC yield use different methodologies. Payouts may include income, capital gains, or return of capital.
| Ex-date | Pay date | Per share |
|---|---|---|
| 2025-12-23 | 2025-12-31 | $0.91 |
| 2025-09-23 | 2025-09-30 | $0.10 |
| 2025-06-24 | 2025-07-01 | $0.22 |
| 2025-03-25 | 2025-04-01 | $0.11 |
| 2024-06-25 | 2024-07-02 | $0.15 |
| 2024-03-19 | 2024-03-26 | $0.16 |
| 2023-12-21 | 2023-12-29 | $0.21 |
| 2023-09-19 | 2023-09-26 | $0.04 |
| 2023-06-21 | 2023-06-28 | $0.18 |
| 2019-12-23 | 2019-12-31 | $0.11 |
| 2019-09-24 | 2019-10-01 | $0.22 |
| 2019-06-25 | 2019-07-02 | $0.74 |
Estimated annual expense excludes trading costs and assumes constant assets. Fee waivers and fund costs can change.
Historical risk measures describe past behavior and do not predict future returns.
Hear the strategy from the people behind LABU.